Cargando…

Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency

Mevalonate kinase deficiency (MKD) is a rare hereditary autoinflammatory disease, with a widely variable clinical spectrum. It is characterized by febrile recurrent episodes and systemic inflammation. Data on therapeutic options for MKD are still limited and remain unknown in our country. We report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souali, Manal, Sakhi, Asmaa, Bousfiha, Ahmed Aziz, Bouayed, Kenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605664/ https://www.ncbi.nlm.nih.gov/pubmed/37901181 http://dx.doi.org/10.1177/2333794X231207351

Ejemplares similares

Spectrum of auto-inflammatory diseases in Morocco: a monocentric experience
por: Souali, Manal, et al.
Publicado: (2023)

Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra
por: Peciuliene, Skaiste, et al.
Publicado: (2016)

Biotherapy in juvenile idiopathic arthritis Moroccan patients: a single-center experience
por: Bouayed, Kenza, et al.
Publicado: (2022)

Clinical and serological correlation of systemic sclerosis in Moroccan patients
por: Ouazahrou, Kaoutar, et al.
Publicado: (2023)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)

The systemic lupus erythematous in paediatrics: Moroccan experience of a unit of pediatric rheumatology
por: Bouayed, Kenza, et al.
Publicado: (2014)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency
por: Jeyaratnam, Jerold, et al.
Publicado: (2022)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Weekly oral alendronate in mevalonate kinase deficiency
por: Cantarini, Luca, et al.
Publicado: (2013)

Isolated neurological presentations of mevalonate kinase deficiency
por: Hoytema van Konijnenburg, Eva M. M., et al.
Publicado: (2022)

Two Siblings With Recurrent Fevers: The Path to Mevalonate Kinase Deficiency Diagnosis
por: Pereira-Nunes, Joana, et al.
Publicado: (2023)

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

OR11-001 - Protein misfolding in mevalonate kinase deficiency
por: Stojanov, S, et al.
Publicado: (2013)

Mevalonate kinase deficiency and IBD: shared genetic background
por: Bianco, Anna Monica, et al.
Publicado: (2014)

Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
por: Jeyaratnam, Jerold, et al.
Publicado: (2020)

Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study
por: Tricarico, Paola Maura, et al.
Publicado: (2013)

Diagnostic value of urinary mevalonic acid excretion in patietns with a clinical suspicion of mevalonate kinase deficiency (MKD)
por: Jeyaratnam, J, et al.
Publicado: (2015)

PReS-FINAL-2212: Mevalonate kinase deficiency: different faces with separate treatments
por: Gençpınar, P, et al.
Publicado: (2013)

PW02-020 - Colitis revealing mevalonate kinase deficiency
por: Michael, L, et al.
Publicado: (2013)

Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis
por: Tricarico, Paola Maura, et al.
Publicado: (2013)

Natural history of mevalonate kinase deficiency: a literature review
por: Zhang, Shumin
Publicado: (2016)

Mevalonate kinase deficiency: an early onset inflammatory bowel disease?
por: Martins, A, et al.
Publicado: (2015)

Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
por: Jeyaratnam, J, et al.
Publicado: (2015)

Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency
por: Ruiz-Ortiz, E, et al.
Publicado: (2015)

Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases
por: Jurczyluk, Julie, et al.
Publicado: (2016)

Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
por: Politiek, Frouwkje A., et al.
Publicado: (2021)

Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency
por: Henneman, L., et al.
Publicado: (2010)

Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?
por: Mulders-Manders, C. M., et al.
Publicado: (2015)

Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency()
por: Bifulco, Maurizio
Publicado: (2015)

Febrile attacks triggered by milk allergy in an infant with mevalonate kinase deficiency
por: Nakashimai, Hideyuki, et al.
Publicado: (2016)

Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency
por: Munoz, Marcia A., et al.
Publicado: (2019)

A case of neonatal sweet syndrome associated with mevalonate kinase deficiency
por: Irwin, Margaret, et al.
Publicado: (2023)

Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report
por: Omoyinmi, Ebun, et al.
Publicado: (2021)

Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
por: Rimondi, Erika, et al.
Publicado: (2021)

Classification of common variable immunodeficiency through immunological and clinical phenotyping in Moroccan patients
por: Mokhantar, Khaoula, et al.
Publicado: (2023)

Mevalonate kinase deficiency (MKD): long-term follow-up of clinical and biological features in 40 patients
por: Florkin, B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hifl4fsngtsfup8ehm52tv4i56